Vancouver’s Sonic Incytes has completed a $9.3 million Series A round led by Nimbus Synergies. The strategic equity round, which was oversubscribed by 150%, comes after the launch of Velacur, the first handheld 3D liver health assessment solution, in the US market in early 2021. Cleared by the FDA, Velacur is a handheld, point of […]
Sonic Incytes
Matidor Named Finalist at SXSW Pitch Competition
The South by Southwest Conference (SXSW) has announced the finalists for the 13th annual SXSW Pitch event, taking place virtually on March 17-18 as part of the SXSW Online digital experience. This competition takes place during SXSW Online 2021, with 40 startups chosen to compete based on the technological innovation brought to their fields. One […]
Sonic Incytes Closes $3.5 Million Round In Fight Against Liver Disease
Vancouver based Sonic Incytes has completing a seed financing round of over $3.5 million. Sonic Incytes is developing a breakthrough, point of care ultrasound solution for assessing and managing chronic liver disease – an emerging global health crisis, affecting one in four persons worldwide. Investors include Small World Group, Think Top Investments and Sunhope Venture […]